Optiver Holding
ANRO icon

Optiver Holding’s Alto Neuroscience ANRO Stock Holding History

Optiver Holding’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90 Sell
4
-16
-80% -$297 ﹤0.01% 2245
2025
Q4 		$356 Hold
20
– – ﹤0.01% 2325
2025
Q3 		$80 Buy
+20
New +$66 ﹤0.01% 2604

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Optiver Holding's ANRO Position: Q1 2026 in Review

Optiver Holding reduced its Alto Neuroscience (ANRO) stake by 80% in Q1 2026, selling an estimated $297 and leaving 4 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Optiver Holding first reported a position in ANRO in Q3 2025 and has held it in 3 quarters since. The position peaked at $356 in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Optiver Holding held 4 shares of Alto Neuroscience worth $90 as of Q1 2026.
  • Optiver Holding sold 16 Alto Neuroscience shares in Q1 2026, an estimated $297.
  • Alto Neuroscience made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2245 holding.
  • Optiver Holding first reported a position in Alto Neuroscience in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Alto Neuroscience position peaked at $356 in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.